Latest stories on OCS
Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
GlobeNewswire56 · neutralproduct/pr
Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
StockTitan56 · neutralproduct/pr
H.C. Wainwright reiterates Buy on Oculis stock, $39 target on biomarker data
Investing.com Analyst Ratings63 · neutralanalyst
Oculis reports Phase 2 data supporting Privosegtor in optic neuritis
The Fly64 · neutralproduct/pr
Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis
StockTitan63 · neutralproduct/pr
Oculis finishes PREDICT-1 randomization with 176 patients, putting a genotype-guided dry eye readout on the 2026 calendar
October 20, 2026
MarketChameleon61 · neutralproduct/pr
Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting
Business Insider58 · neutralproduct/pr
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease
Business Insider63 · neutralproduct/pr
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
StockTitan63 · neutralproduct/pr
Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
Business Insider56 · neutralgeneral
Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
GlobeNewswire56 · neutralgeneral
Oculis Holding Announces Board Resignation of Long-Serving Director Lionel Carnot
TipRanks50 · neutralgeneral
Oculis Announces Resignation of Lionel Carnot from Board of Directors
StockTitan48 · neutralgeneral
Stifel reiterates Buy rating on Oculis stock, $40 target
Investing.com Analyst Ratings61 · neutralanalyst
Oculis price target raised to $39 from $26 at H.C. Wainwright
The Fly67 · bullishanalyst
Oculis Holding AG: Navigating Through Major Trial Setback
Seeking Alpha28 · bearishgeneral
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
StockTitan50 · neutralgeneral
Wall Street Analysts Believe Oculis Holding AG (OCS) Could Rally 199.75%: Here's is How to Trade
Quartz62 · neutralanalyst
H.C. Wainwright reiterates Oculis stock rating on trial start
Investing.com Analyst Ratings56 · neutralanalyst
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
Business Insider59 · neutralgeneral
Oculis price target lowered to $20 from $23 at JPMorgan
The Fly34 · bearishanalyst
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
StockTitan50 · neutralgeneral
Stifel reiterates Buy rating on Oculis stock, $40 target
Investing.com Analyst Ratings61 · neutralanalyst
Oculis to Acquire Full Rights to Privosegtor in Asset Deal with Accure Therapeutics
TipRanks63 · neutralm&a